RightEye Enters Into Agreement With MIT to Research Ocular Biomarker ‘Signature’ for Lyme Disease
Posted in: Press Releases
CDC Reports Lyme Disease Cases Tripling. Current Testing Methods Have Significant Shortcomings BETHESDA, Md., April 25, 2022 (Newswire.com) – RightEye, the world’s leading eye-tracking biomarker company, has signed a research collaboration agreement…